Thomas Bogenrieder
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Papers in
- Oncology 33
- Cutaneous Melanoma Detection and Management 6
- Cancer-related Molecular Pathways 6
- Peptidase Inhibition and Analysis 6
-
- Melanoma and MAPK Pathways 6
- Co-authors
- Meenhard Herlyn (8 shared papers)Ulrike Weyer-Czernilofsky (7 shared papers)Kapaettu Satyamoorthy (3 shared papers)Dirk J. Ruiter (1 shared paper)David E. Elder (1 shared paper)Anthony P. Albino (9 shared papers)David M. Nanus (9 shared papers)Christos N. Papandreou (9 shared papers)
- Journals
- Cancer Research (7 papers)Annals of Oncology (5 papers)Journal of Clinical Oncology (5 papers)Oncogene (4 papers)Melanoma Research (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Thomas Bogenrieder
60 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 107
- Oncology 1.2k
- Immunology and Allergy 236
- Cancer Research 536
- Immunology 371
- Molecular Biology 1.2k
Countries citing papers authored by Thomas Bogenrieder
This map shows the geographic impact of Thomas Bogenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bogenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bogenrieder more than expected).
Fields of papers citing papers by Thomas Bogenrieder
This network shows the impact of papers produced by Thomas Bogenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bogenrieder. The network helps show where Thomas Bogenrieder may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Bogenrieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 476 | |
| 2 | 1998 | 234 | |
| 3 | 2016 | 193 | |
| 4 | 2002 | 185 | |
| 5 | 2002 | 136 | |
| 6 | 2003 | 134 | |
| 7 | 2017 | 125 | |
| 8 | 2010 | 76 | |
| 9 | 1997 | 73 | |
| 10 | 2018 | 69 | |
| 11 | 2003 | 69 | |
| 12 | 2001 | 61 | |
| 13 | Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. | 1996 | 60 |
| 14 | 2018 | 50 | |
| 15 | 2003 | 45 | |
| 16 | 2001 | 42 | |
| 17 | 1997 | 42 | |
| 18 | 2002 | 41 | |
| 19 | 2012 | 39 | |
| 20 | 2019 | 38 |
About Thomas Bogenrieder
Thomas Bogenrieder is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 63 papers that have together received 2.6k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (8 papers), Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (6 papers), Cancer-related Molecular Pathways (6 papers), Immunotherapy and Immune Responses (6 papers), Peptidase Inhibition and Analysis (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology and Allergy (236 citations), Cancer Research (536 citations), Immunology (371 citations) and Molecular Biology (1.2k citations). Thomas Bogenrieder has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Meenhard Herlyn, Ulrike Weyer-Czernilofsky, Kapaettu Satyamoorthy, Dirk J. Ruiter, David E. Elder, Anthony P. Albino, David M. Nanus, Christos N. Papandreou, Carola Berking and Valentine M. Macaulay. Their work appears in journals such as Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Oncogene and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.